Journal article
Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy
Abstract
BACKGROUND: Models to predict the outcome of patients with metastatic urothelial cancer (UC), based on pretreatment variables, have previously been developed. However, patients often request "updated" prognostic estimates based upon their response to treatment.
PATIENTS AND METHODS: Data were pooled from 317 patients enrolled in 8 trials evaluating first-line cisplatin-based chemotherapy in metastatic UC. Variables were combined in the Cox …
Authors
Galsky MD; Moshier E; Krege S; Lin C-C; Hahn N; Ecke T; Sonpavde G; Pond G; Godbold J; Oh WK
Journal
Urologic Oncology Seminars and Original Investigations, Vol. 32, No. 1, pp. 48.e1–48.e8
Publisher
Elsevier
Publication Date
January 2014
DOI
10.1016/j.urolonc.2013.07.001
ISSN
1078-1439
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Transitional CellCisplatinClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicHumansMiddle AgedModels, BiologicalNeoplasm MetastasisOutcome Assessment, Health CarePrognosisProportional Hazards ModelsSurvival AnalysisUrologic Neoplasms